My Web Dashboard





SEO News: Study Shows Patient Preference For Gonal-f(R) RFF Pen To Treat Infertility (Medical News Today)

Serono (virt-x: SEO and NYSE: SRA) today announced the results of a Phase IIIb, prospective, open-label study in which patients reported that they preferred the Gonal-f(R) RFF Pen (follitropin alfa injection) to their previous fertility treatment with conventional vials/ampules and syringes. [click link for full article]

read more...

Related News